Revealing Clonal Responses of Tumor-Reactive T-Cells Through T Cell Receptor Repertoire Analysis

Front Immunol. 2022 Jan 27:13:807696. doi: 10.3389/fimmu.2022.807696. eCollection 2022.

Abstract

CD8+ T cells are the key effector cells that contribute to the antitumor immune response. They comprise various T-cell clones with diverse antigen-specific T-cell receptors (TCRs). Thus, elucidating the overall antitumor responses of diverse T-cell clones is an emerging challenge in tumor immunology. With the recent advancement in next-generation DNA sequencers, comprehensive analysis of the collection of TCR genes (TCR repertoire analysis) is feasible and has been used to investigate the clonal responses of antitumor T cells. However, the immunopathological significance of TCR repertoire indices is still undefined. In this review, we introduce two approaches that facilitate an immunological interpretation of the TCR repertoire data: inter-organ clone tracking analysis and single-cell TCR sequencing. These approaches for TCR repertoire analysis will provide a more accurate understanding of the response of tumor-specific T cells in the tumor microenvironment.

Keywords: CD8+ T cell; T-cell receptor repertoire; cancer-immunity cycle; immune check inhibitors; inter-organ clone tracking; single-cell TCR-seq.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • CD8-Positive T-Lymphocytes / immunology
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Lymphocyte Activation / immunology
  • Mice
  • Neoplasms / immunology*
  • Receptors, Antigen, T-Cell / classification
  • Receptors, Antigen, T-Cell / genetics*
  • Receptors, Antigen, T-Cell / immunology*
  • Tumor Microenvironment / immunology*

Substances

  • Receptors, Antigen, T-Cell